These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 11813875)

  • 41. Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Imafuku A; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabet Med; 2015 Apr; 32(4):546-55. PubMed ID: 25400024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tubular changes in early diabetic nephropathy.
    Thomas MC; Burns WC; Cooper ME
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):177-86. PubMed ID: 15822053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tubulitis in primary vascular and glomerular renal disease.
    Iványi B; Marcussen N; Olsen S
    Pathol Res Pract; 1995 Dec; 191(12):1245-57. PubMed ID: 8927573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myofibroblast involvement in tubular basement membrane remodeling in type II diabetic nephropathy.
    Mandache E; Gherghiceanu M; Serafinceanu C; Penescu M; Mircescu G
    Rom J Morphol Embryol; 2011; 52(1):75-9. PubMed ID: 21424035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats.
    Tucker BJ; Rasch R; Blantz RC
    J Clin Invest; 1993 Aug; 92(2):686-94. PubMed ID: 8349807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrophage accumulation in human progressive diabetic nephropathy.
    Nguyen D; Ping F; Mu W; Hill P; Atkins RC; Chadban SJ
    Nephrology (Carlton); 2006 Jun; 11(3):226-31. PubMed ID: 16756636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy.
    Lanaspa MA; Ishimoto T; Cicerchi C; Tamura Y; Roncal-Jimenez CA; Chen W; Tanabe K; Andres-Hernando A; Orlicky DJ; Finol E; Inaba S; Li N; Rivard CJ; Kosugi T; Sanchez-Lozada LG; Petrash JM; Sautin YY; Ejaz AA; Kitagawa W; Garcia GE; Bonthron DT; Asipu A; Diggle CP; Rodriguez-Iturbe B; Nakagawa T; Johnson RJ
    J Am Soc Nephrol; 2014 Nov; 25(11):2526-38. PubMed ID: 24876114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.
    Vallon V; Thomson SC
    Annu Rev Physiol; 2012; 74():351-75. PubMed ID: 22335797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Why is proteinuria such an important risk factor for progression in clinical trials?
    Jerums G; Panagiotopoulos S; Tsalamandris C; Allen TJ; Gilbert RE; Comper WD
    Kidney Int Suppl; 1997 Dec; 63():S87-92. PubMed ID: 9407431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J
    Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kidney atrophy vs hypertrophy in diabetes: which cells are involved?
    Habib SL
    Cell Cycle; 2018; 17(14):1683-1687. PubMed ID: 29995580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteinuria: clinical signficance and basis for therapy.
    Woo KT; Lau YK
    Singapore Med J; 2001 Aug; 42(8):385-9. PubMed ID: 11764058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats.
    Li C; Yang CW; Park CW; Ahn HJ; Kim WY; Yoon KH; Suh SH; Lim SW; Cha JH; Kim YS; Kim J; Chang YS; Bang BK
    Kidney Int; 2003 Feb; 63(2):454-63. PubMed ID: 12631111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.
    Wada T; Furuichi K; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Takeda SI; Takasawa K; Yoshimura M; Kida H; Kobayashi KI; Mukaida N; Naito T; Matsushima K; Yokoyama H
    Kidney Int; 2000 Oct; 58(4):1492-9. PubMed ID: 11012884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
    Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
    Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy.
    Singh DK; Winocour P; Farrington K
    Nat Clin Pract Nephrol; 2008 Apr; 4(4):216-26. PubMed ID: 18268525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice.
    Powell DW; Bertram CC; Cummins TD; Barati MT; Zheng S; Epstein PN; Klein JB
    Nephron Exp Nephrol; 2009; 111(1):e11-9. PubMed ID: 19052473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.